Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: Impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP

Annals of the Rheumatic Diseases

Volumn 71, Issue 6, 2012, Pages 851-856

  Hetland, Merete Lund ^a   Østergaard, Mikkel ^a   Ejbjerg, Bo ^b   Jacobsen, Søren ^c   Stengaard Pedersen, Kristian ^d   Junker, Peter ^e   Lottenburger, Tine ^f   Hansen, Ib ^d   Andersen, Lis Smedegaard ^g   Tarp, Ulrik ^d   Svendsen, Anders ^f   Pedersen, Jens Kristian ^g   Skjødt, Henrik ^a   Ellingsen, Torkell ^d   Lindegaard, Hanne ^e   Pødenphant, Jan ^h   Hørslev Petersen, Kim ^g   Jensen, S H ⁱ   Lorenzen, T ⁱ   Bendtsen, H ^h   Faarvang, K L ^h   Hansen, M S ^h   Hansen, T M ^h   Nielsen, H ^h   Jacobsen, S ^j   Lauridsen, U B ^j   Majgaard, O ^j   Beier, J ^e   Ejstrup, L ^e   Knudsen, J B ^e   Lasutrup, H ^e   Krogh, N S ^k   Gerdes, L ^d   Frederisken, J ⁱ   Rasmussen, P ⁱ   Theilgard K ⁱ   Bukh, G ^h   Pedersen Zbinden, B ^j   Holm, H ^e   Lorentzen, K B ^e   more..

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b SLAGELSE HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

^f LILLEBAELT HOSPITAL   (Denmark)

^g UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^h GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

ⁱ Imaging group   (Denmark)

^j HVIDOVRE HOSPITAL   (Denmark)

^k Odense Hospital ^*  (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BETAMETHASONE; C REACTIVE PROTEIN; CALCIUM; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; IMMUNOGLOBULIN M; METHOTREXATE; RHEUMATOID FACTOR; VITAMIN D;

ANKLE; ARTICLE; ASEPTIC NECROSIS; BACTERIAL ARTHRITIS; CONTROLLED STUDY; DISEASE CONTROL; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; EARLY RHEUMATOID ARTHRITIS; ELBOW; FOLLOW UP; HUMAN; INJECTION; JOINT INJECTION SURVIVAL; KAPLAN MEIER METHOD; KNEE; MAJOR CLINICAL STUDY; MEASUREMENT; METACARPOPHALANGEAL JOINT; METATARSOPHALANGEAL JOINT; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SHOULDER; SPINE FRACTURE; SYNOVITIS; TIME; UNSPECIFIED SIDE EFFECT; WRIST;

ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BETAMETHASONE; C-REACTIVE PROTEIN; DRUG THERAPY, COMBINATION; EARLY DIAGNOSIS; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN M; INJECTIONS, INTRA-ARTICULAR; JOINTS; MAGNETIC RESONANCE IMAGING; PEPTIDES, CYCLIC; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RHEUMATOID FACTOR; TIME; TREATMENT OUTCOME;

EID: 84860915073     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200632     Document Type: Article

References (22)

1. Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N Engl J Med 1995;333:142-6.
2. Pincus T, Sokka T, Stein CM. Are long-term very low doses of prednisone for patients with rheumatoid arthritis as helpful as high doses are harmful? Ann Intern Med 2002;136:76-8. (Pubitemid 34038699)
3. Conaghan PG, O'Connor P, McGonagle D, et al. Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis. Arthritis Rheum 2003;48:64-71. (Pubitemid 36091649)
4. Svensson B, Boonen A, Albertsson K, et al. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial. Arthritis Rheum 2005;52:3360-70. (Pubitemid 41612202)
5. Proudman SM, Conaghan PG, Richardson C, et al. Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone. Arthritis Rheum 2000;43:1809-19.
6. Grigor C, Capell H, Stirling A, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004;364:263-9. (Pubitemid 38942816)
7. Hetland ML, Stengaard-Pedersen K, Junker P, et al. Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study. Arthritis Rheum 2006;54:1401-9.
8. Hetland ML, Stengaard-Pedersen K, Junker P, et al. Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study. Ann Rheum Dis 2008;67:815-22. (Pubitemid 351829382)
9. van Gestel AM, Prevoo ML, van 't Hof MA, et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996;39:34-40. (Pubitemid 26036375)
10. Hetland ML, Stengaard-Pedersen K, Junker P, et al. Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial. Ann Rheum Dis 2010;69:1789-95.
11. Nishimura K, Sugiyama D, Kogata Y, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 2007;146:797-808. (Pubitemid 351650500)
12. Vasiliauskiene L, Wiik A, Høier-Madsen M. Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis. Ann Rheum Dis 2001;60:459-66. (Pubitemid 32417417)
13. Hetland ML, Ejbjerg B, Hørslev-Petersen K, et al. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Ann Rheum Dis 2009;68:384-90.
14. Østergaard M, Peterfy C, Conaghan P, et al. OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol 2003;30:1385-6. (Pubitemid 36666373)
15. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, http://www.R-project.org. (computer program). Vienna, Austria: R Foundation for Statistical Computing 2006.
16. Boers M, Verhoeven AC, Markusse HM, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997;350:309-18. (Pubitemid 27351112)
17. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005;52:3381-90. (Pubitemid 41612204)
18. Furtado RN, Oliveira LM, Natour J. Polyarticular corticosteroid injection versus systemic administration in treatment of rheumatoid arthritis patients: a randomized controlled study. J Rheumatol 2005;32:1691-8. (Pubitemid 41324805)
19. Jacobsen S, Garred P, Madsen HO, et al. Mannose-binding lectin gene polymorphisms are associated with disease activity and physical disability in untreated, anti-cyclic citrullinated peptide-positive patients with early rheumatoid arthritis. J Rheumatol 2009;36:731-5.
20. Christensen AF, Lindegaard H, Hørslev-Petersen K, et al. Cartilage oligomeric matrix protein associates differentially with erosions and synovitis and has a different temporal course in cyclic citrullinated peptide antibody (anti-CCP)-positive versus anti-CCP-negative early rheumatoid arthritis. J Rheumatol 2011;38:1563-8.
21. Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. Lancet 2009;373:659-72.
22. Kuhn KA, Kulik L, Tomooka B, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006;116:961-73.